| 前收市價 | 160.50 |
| 開市 | 159.63 |
| 買盤 | 160.11 x 800 |
| 賣出價 | 160.42 x 800 |
| 今日波幅 | 158.77 - 160.49 |
| 52 週波幅 | 143.13 - 168.85 |
| 成交量 | |
| 平均成交量 | 6,606,623 |
| 市值 | 385.856十億 |
| Beta 值 (5 年，每月) | 0.52 |
| 市盈率 (最近 12 個月) | 24.29 |
| 每股盈利 (最近 12 個月) | 6.60 |
| 業績公佈日 | 2024年10月15日 |
| 遠期股息及收益率 | 4.96 (3.09%) |
| 除息日 | 2024年8月27日 |
| 1 年預測目標價 | 172.31 |
BenzingaJohnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
On Friday, Johnson & Johnson (NYSE:JNJ) announced discontinuing the Phase 2 field study evaluating the efficacy of investigational antiviral candidate mosnodenvir to prevent dengue virus in adults aged 18-65. The decision to discontinue this study is part of a strategic reprioritization of the company’s Communicable Diseases research and development (R&D) portfolio. No safety issues were identified. Efficacy data from the Phase 2 field study will be available once the final data analyses, which
BloombergSanofi Healthcare Bidders Revising Offers Over Talc Concerns
(Bloomberg) -- Bidders for Sanofi’s consumer healthcare unit are revising their offers in part to address concerns around potential liabilities related to a brand that sold talcum powder, according to people with knowledge of the matter. Most Read from BloombergWhat Do US Vehicle Regulators Have Against Tiny Cars?Mexico City Restricts Airbnb Rentals to Curb ‘Gentrification’NYC Schools Reverse Course on Cell-Phone Ban After Parents BalkThe Corner Store ComebackRoofs of Mexico City’s Massive Food
ReutersJ&J discontinues dengue drug study after changes in R&D portfolio
In a separate emailed statement, J&J also said it will also "explore opportunities to advance the clinical development of mosnodenvir outside the company, so that others may build on our research." Six of 10 participants on the drug showed no detectable dengue virus in their blood after being injected with a type of the pathogen, according to data that was presented by J&J in October last year from another mid-stage study. J&J said that efficacy data from the field study will be available once the final data analyses are complete.
